CJ, L., E, M., B, B., S, S., P, R., JY, B., . . . P, S. (2021). Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial. Cancers, 13(23), . https://doi.org/10.3390/cancers13236057
Chicago Style (17th ed.) CitationCJ, Lee, et al. "Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial." Cancers 13, no. 23 (2021). https://doi.org/10.3390/cancers13236057.
MLA (9th ed.) CitationCJ, Lee, et al. "Histopathological and Molecular Profiling of Clear Cell Sarcoma and Correlation with Response to Crizotinib: An Exploratory Study Related to EORTC 90101 "CREATE" Trial." Cancers, vol. 13, no. 23, 2021, https://doi.org/10.3390/cancers13236057.